The role of inflammation as a pathogenic factor in the development of renal disease in diabetes Carmen MoraJuan F. Navarro Invited Commentary Pages: 399 - 401
Newer agents for the treatment of painful diabetic peripheral neuropathy Roy Freeman OriginalPaper Pages: 409 - 416
Recent developments in the assessment of efficacy in clinical trials of diabetic neuropathy Moaz MojaddidiCristian QuattriniRayaz A. Malik OriginalPaper Pages: 417 - 422
The pivotal role of offloading in the management of neuropathic foot ulceration Stephanie C. WuRyan T. CrewsDavid G. Armstrong OriginalPaper Pages: 423 - 429
Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy William J. Jeffcoate OriginalPaper Pages: 430 - 435
2005: The International Diabetes Federation focuses on the diabetic foot Karel BakkerWilliam H. van HoutumPhil C. Riley OriginalPaper Pages: 436 - 440
Microalbuminuria is a poor predictor for progression of diabetic kidney disease in young type 1 diabetic patients Robert Stanton Clinical Trials Report Pages: 443 - 444
Lipids and diabetic renal disease Mark E. CooperKarin A. M. Jandeleit-Dahm OriginalPaper Pages: 445 - 448
Pathogenic role of nitric oxide alterations in diabetic nephropathy Sharma S. Prabhakar OriginalPaper Pages: 449 - 454
Early nephropathy in type 1 diabetes: A new perspective on who will and who will not progress Bruce A. PerkinsAndrzej S. Krolewski OriginalPaper Pages: 455 - 463
